4
Changes in Ownership
Structure Therapeutics Inc. Filed Acc 0001962926-26-000006
CHIEF SCIENTIFIC OFFICER acquired 23,634 shares (option exercise)
- CHIEF SCIENTIFIC OFFICER acquired 23,634 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-07-14 | Option exercise 10b5-1 | +23,634 | $0.34 | $8,036 | 252,594 | D: show line 1 in the form |
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-07-14 | Conversion 10b5-1 | −23,634 | 228,960 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-07-14 | Option exercise · Share Option (right to buy) 10b5-1 | −23,634 | 166,532 | D: show line 3 in the form | ||
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-07-14 | Conversion · American Depositary Shares 10b5-1 | +7,878 | 7,878 | D: show line 4 in the form | ||
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-07-14 | Sale · American Depositary Shares 10b5-1 | −6,278 | $50.80 | $318,895 | 1,600 | D: show line 5 in the form |
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-07-14 | Sale · American Depositary Shares 10b5-1 | −1,600 | $51.71 | $82,734 | 0 | D: show line 6 in the form |
Loading xslF345X06/form4-07152026_100751.xml…